FDA Approval Medical Schools Molecular Biology 
Drug Target Review
AUGUST 29, 2024
MR : Chimeric antigen receptor T-cell (CAR-T) therapy is very effective in treating patients with B-cell lymphoma, leukemia, and multiple myeloma, where we have six FDA-approved drugs. What potential advantages does the CD5 modulation strategy offer over traditional CAR-T therapies?
Broad Institute
APRIL 25, 2024
The project is a collaboration between the Broad and the African Center of Excellence for Genomics of Infectious Diseases (ACEGID) at Redeemer’s University outside Lagos in Nigeria, where Happi is a professor of molecular biology and genomics.
Drug Target Review
FEBRUARY 15, 2024
Advances in molecular biology have led to highly safe, efficient, and effective platforms, such as mRNA, that can be rapidly re-purposed for different pathogens, multiple pathogens, or new strains of evolving pathogens. He currently serves as Chief Medical Officer at SIGA Technologies. References Morens D, Fauci A.
Expert insights. Personalized for you.
59 
Let's personalize your content